FABP4 as a biomarker for knee osteoarthritis

Chaofan Zhang; Teng Li; Kwong Yuen Chiu; Chunyi Wen; Aimin Xu; Chun Hoi Yan

doi:10.2217/bmm-2017-0207

FABP4 as a biomarker for knee osteoarthritis

Chaofan Zhang
, Teng Li
, Kwong Yuen Chiu
, Chunyi Wen
, Aimin Xu
, Chun Hoi Yan

Research output: Journal article publication › Journal article › Academic research › peer-review

33 Citations (Scopus)

Abstract

Aim: To explore the role of an adipokine-termed fatty acid-binding protein 4 (FABP4) in osteoarthritis (OA). Methods: Patients with primary knee OA and non-OA controls were included. Paired tissues including plasma, synovial fluid (SF), subcutaneous fat and infrapatellar fat pad (IPFP) were harvested during surgery. FABP4 concentration was determined by ELISA. Results: Plasma FABP4 increased significantly with OA stage (n = 263). OA patients (n = 38) had significantly higher plasma and SF FABP4 than non-OA patients (n = 29). FABP4 level of IPFP was positively correlated with SF FABP4. Conclusion: OA patients had significantly high systemic and local FABP4, and IPFP may be the main source of FABP4 in synovial cavity. FABP4 may be a promising biomarker for OA.

Original language	English
Pages (from-to)	107-118
Number of pages	12
Journal	Biomarkers in Medicine
Volume	12
Issue number	2
DOIs	https://doi.org/10.2217/bmm-2017-0207
Publication status	Published - 1 Feb 2018

Keywords

FABP4
infrapatellar fat pad
osteoarthritis

ASJC Scopus subject areas

Drug Discovery
Clinical Biochemistry
Biochemistry, medical

More information

10.2217/bmm-2017-0207

Cite this

@article{a52969ec6a7d4db7b31a4d43861b0027,

title = "FABP4 as a biomarker for knee osteoarthritis",

abstract = "Aim: To explore the role of an adipokine-termed fatty acid-binding protein 4 (FABP4) in osteoarthritis (OA). Methods: Patients with primary knee OA and non-OA controls were included. Paired tissues including plasma, synovial fluid (SF), subcutaneous fat and infrapatellar fat pad (IPFP) were harvested during surgery. FABP4 concentration was determined by ELISA. Results: Plasma FABP4 increased significantly with OA stage (n = 263). OA patients (n = 38) had significantly higher plasma and SF FABP4 than non-OA patients (n = 29). FABP4 level of IPFP was positively correlated with SF FABP4. Conclusion: OA patients had significantly high systemic and local FABP4, and IPFP may be the main source of FABP4 in synovial cavity. FABP4 may be a promising biomarker for OA.",

keywords = "FABP4, infrapatellar fat pad, osteoarthritis",

author = "Chaofan Zhang and Teng Li and Chiu, \{Kwong Yuen\} and Chunyi Wen and Aimin Xu and Yan, \{Chun Hoi\}",

year = "2018",

month = feb,

day = "1",

doi = "10.2217/bmm-2017-0207",

language = "English",

volume = "12",

pages = "107--118",

journal = "Biomarkers in Medicine",

issn = "1752-0363",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - FABP4 as a biomarker for knee osteoarthritis

AU - Zhang, Chaofan

AU - Li, Teng

AU - Chiu, Kwong Yuen

AU - Wen, Chunyi

AU - Xu, Aimin

AU - Yan, Chun Hoi

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Aim: To explore the role of an adipokine-termed fatty acid-binding protein 4 (FABP4) in osteoarthritis (OA). Methods: Patients with primary knee OA and non-OA controls were included. Paired tissues including plasma, synovial fluid (SF), subcutaneous fat and infrapatellar fat pad (IPFP) were harvested during surgery. FABP4 concentration was determined by ELISA. Results: Plasma FABP4 increased significantly with OA stage (n = 263). OA patients (n = 38) had significantly higher plasma and SF FABP4 than non-OA patients (n = 29). FABP4 level of IPFP was positively correlated with SF FABP4. Conclusion: OA patients had significantly high systemic and local FABP4, and IPFP may be the main source of FABP4 in synovial cavity. FABP4 may be a promising biomarker for OA.

AB - Aim: To explore the role of an adipokine-termed fatty acid-binding protein 4 (FABP4) in osteoarthritis (OA). Methods: Patients with primary knee OA and non-OA controls were included. Paired tissues including plasma, synovial fluid (SF), subcutaneous fat and infrapatellar fat pad (IPFP) were harvested during surgery. FABP4 concentration was determined by ELISA. Results: Plasma FABP4 increased significantly with OA stage (n = 263). OA patients (n = 38) had significantly higher plasma and SF FABP4 than non-OA patients (n = 29). FABP4 level of IPFP was positively correlated with SF FABP4. Conclusion: OA patients had significantly high systemic and local FABP4, and IPFP may be the main source of FABP4 in synovial cavity. FABP4 may be a promising biomarker for OA.

KW - FABP4

KW - infrapatellar fat pad

KW - osteoarthritis

UR - https://www.scopus.com/pages/publications/85041399149

U2 - 10.2217/bmm-2017-0207

DO - 10.2217/bmm-2017-0207

M3 - Journal article

C2 - 29393670

AN - SCOPUS:85041399149

SN - 1752-0363

VL - 12

SP - 107

EP - 118

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

IS - 2

ER -

FABP4 as a biomarker for knee osteoarthritis

Abstract

Keywords

ASJC Scopus subject areas

More information

Other files and links

Fingerprint

Cite this